Regulation of proliferation and differentiation of human fetal bone cells

European Cells and Materials

Volumn 21, Issue , 2011, Pages 46-58

  Krattinger, Nathalie ^a   Applegate, Lee A ^b   Biver, Emmanuel ^c   Pioletti, Dominique P ^a   Caverzasio, Joseph ^c  

^a EPFL   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Differentiation; Environmental conditions; Fetal bone cells; Growth factors; Mesenchymal stem cells; Proliferation

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; FIBROBLAST GROWTH FACTOR 2; PLATELET DERIVED GROWTH FACTOR; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9;

ARTICLE; BONE CELL; BONE DEVELOPMENT; BONE MINERALIZATION; CELL COUNT; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMUR; FETUS; FETUS CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCHYMAL STEM CELL; NUCLEOTIDE SEQUENCE; OSTEOBLAST;

EID: 79551522604     PISSN: 14732262     EISSN: None     Source Type: Journal    
DOI: 10.22203/eCM.v021a04     Document Type: Article

References (48)

1. Applegate LA, Scaletta C, Hirt-Burri N, Raffoul W, Pioletti D (2009) Whole-cell bioprocessing of human fetal cells for tissue engineering of skin. Skin Pharmacol Physiol 22: 63-73.
2. Bianco P, Riminucci M, Gronthos S, Robey PG (2001) Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19: 180-192.
3. Caplan AI, Bruder SP (2001) Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med 7: 259-264.
4. Chamberlain JR, Schwarze U, Wang PR, Hirata RK, Hankenson KD, Pace JM, Underwood RA, Song KM, Sussman M, Byers PH, Russell DW (2004) Gene targeting in stem cells from individuals with osteogenesis imperfecta. Science 303: 1198-1201.
5. Clarkson ED (2001) Fetal tissue transplantation for patients with Parkinson's disease: a database of published clinical results. Drugs Aging 18: 773-785.
6. De Buys Roessingh AS, Hohlfeld J, Scaletta C, Hirt-Burri N, Gerber S, Hohlfeld P, Gebbers JO, Applegate LA (2006) Development, characterization, and use of a fetal skin cell bank for tissue engineering in wound healing. Cell Transplant 15: 823-834.
7. Frank O, Heim M, Jakob M, Barbero A, Schafer D, Bendik I, Dick W, Heberer M, Martin I (2002) Real-time quantitative RT-PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro. J Cell Biochem 85: 737-746.
8. Friedenstein AJ, Gorskaja JF, Kulagina NN (1976) Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4: 267-274.
9. Gregory CA, Gunn WG, Peister A, Prockop DJ (2004) An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem 329: 77-84.
10. Hirt-Burri N, de Buys Roessingh AS, Scaletta C, Gerber S, Pioletti DP, Applegate LA, Hohlfeld J (2008a) Human muscular fetal cells: a potential cell source for muscular therapies. Pediatr Surg Int 24: 37-47.
11. Hirt-Burri N, Scaletta C, Gerber S, Pioletti DP, Applegate LA (2008b) Wound healing gene-family expression differences between fetal and foreskin cells used for bioengineered skin substitutes. Art Organs 37: 509-518.
12. Hock JM, Canalis E (1994) Platelet-derived growth factor enhances bone cell replication, but not differentiated function of osteoblasts. Endocrinology 134: 1423-1428.
13. Hohlfeld J, de Buys Roessingh A, Hirt-Burri N, Chaubert P, Gerber S, Scaletta C, Hohlfeld P, Applegatel A., (2005) Tissue engineered fetal skin constructs for paediatric burns. Lancet 366: 840-842.
14. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, Sussman M, Orchard P, Marx JC, Pyeritz RE and Brenner MK (1999) Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5: 309-313.
15. Horwitz EM, Prockop DJ, Gordon PL, Koo WW, Fitzpatrick LA, Neel MD, McCarville ME, Orchard PJ, Pyeritz RE and Brenner MK (2001) Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 97: 1227-1231.
16. Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY, Muul L, Hofmann T (2002) Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci USA 99: 8932-8937.
17. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, Deans RJ, Krause DS, Keating A (2005) Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 7: 393-395.
18. Hutmacher DW and Sittinger M (2003) Periosteal cells in bone tissue engineering. Tissue Eng 9 Suppl 1: S45-64.
19. Jaiswal N, Haynesworth SE, Caplan AI and Bruder SP (1997) Osteogenic differentiation of purified, cultureexpanded human mesenchymal stem cells in vitro. J Cell Biochem 64: 295-312.
20. Krebsbach PH, Kuznetsov SA, Bianco P and Robey PG (1999) Bone marrow stromal cells: characterization and clinical application. Crit Rev Oral Biol Med 10: 165-181.
21. Le Blanc K, Gotherstrom C, Ringden O, Hassan M, McMahon R, Horwitz E, Anneren G, Axelsson O, Nunn J, Ewald U, Norden-Lindeberg S, Jansson M, Dalton A, Astrom E and Westgren M (2005) Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 79: 1607-1614.
22. Lecanda F, Avioli LV, Cheng SL (1997) Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2. J Cell Biochem 67: 386-396.
23. Liu SB, Hu PZ, Hou Y, Li P, Cao W, Tian Q (2009) Recombinant human bone morphogenetic protein-2 promotes the proliferation of mesenchymal stem cells in vivo and in vitro. Chin Med J (Engl) 122: 839-843.
24. Martin I, Muraglia A, Campanile G, Cancedda R, Quarto R (1997) Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 138: 4456-4462.
25. Matsubara T, Kida K, Yamaguchi A, Hata K, Ichida F, Meguro H, Aburatani H, Nishimura R, Yoneda T (2008) BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation. J Biol Chem 283: 29119-29125.
26. Mauney JR, Volloch V, Kaplan DL (2005) Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects. Tissue Eng 11: 787-802.
27. Mendes SC, Tibbe JM, Veenhof M, Both S, Oner FC, van Blitterswijk CA, de Bruijn JD (2004) Relation between in vitro and in vivo osteogenic potential of cultured human bone marrow stromal cells. J Mater Sci Mater Med 15: 1123-1128.
28. Mirmalek-Sani SH, Tare RS, Morgan SM, Roach HI, Wilson DI, Hanley NA, Oreffo RO (2006) Characterization and multipotentiality of human fetal femur-derived cells: implications for skeletal tissue regeneration. Stem Cells 24: 1042-1053.
29. Mirmalek-Sani SH, Stokes PJ, Tare RS, Ralph EJ, Inglis S, Hanley NA, Houghton FD, Oreffo RO (2009) Derivation of a novel undifferentiated human fetal phenotype in serum-free cultures with BMP-2. J Cell Mol Med 13: 3541-3555.
30. Miyazono K, Kusanagi K, Inoue H (2001) Divergence and convergence of TGF-beta/BMP signaling. Journal of cellular physiology 187: 265-276.
31. Montjovent MO, Burri N, Mark S, Federici E, Scaletta C, Zambelli PY, Hohlfeld P, Leyvraz PF, Applegate LL, Pioletti DP (2004) Fetal bone cells for tissue engineering. Bone 35: 1323-1333.
32. Montjovent MO, Mathieu L, Hinz B, Applegate LL, Bourban PE, Zambelli PY, Manson JA, Pioletti DP (2005) Biocompatibility of bioresorbable poly(L-lactic acid) composite scaffolds obtained by supercritical gas foaming with human fetal bone cells. Tissue Eng 11: 1640-1649.
33. Montjovent MO, Mark S, Mathieu L, Scaletta C, Scherberich A, Delabarde C, Zambelli PY, Bourban PE, Applegate LA, Pioletti DP (2008) Human fetal bone cellsassociated with ceramic reinforced PLA scaffolds for tissue engineering. Bone 42: 554-564.
34. Ohgushi H, Caplan AI (1999) Stem cell technology and bioceramics: from cell to gene engineering. J Biomed Mater Res 48: 913-927.
35. Oreffo RO, Cooper C, Mason C, Clements M (2005) Mesenchymal stem cells: lineage, plasticity, and skeletal therapeutic potential. Stem Cell Rev 1: 169-178.
36. Owen ME, Cave J, Joyner CJ (1987) Clonal analysis in vitro of osteogenic differentiation of marrow CFU-F. J Cell Sci 87: 731-738.
37. Phinney DG, Kopen G, Isaacson RL, Prockop DJ (1999) Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth, and differentiation. J Cell Biochem 72: 570-585.
38. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
39. Quarto R, Mastrogiacomo M, Cancedda R, Kutepov SM, Mukhachev V, Lavroukov A, Kon E, Marcacci M (2001) Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 344:385-386.
40. Quintin A, Hirt-Burri N, Scaletta C, Schizas C, Pioletti DP and Applegate LA (2007) Consistency and safety ofcell banks for research and clinical use: preliminary analysis of fetal skin banks. Cell Transplant 16: 675-684.
41. Ramelet AA, Hirt-Burri N, Raffoul W, Scaletta C, Pioletti DP, Offord E, Mansourian R, Applegate LA (2009) Chronic wound healing by fetal cell therapy may be explained by differential gene profiling observed in fetal versus old skin cells. Exp Gerontol 44: 208-218.
42. Rose FR, Oreffo RO (2002) Bone tissue engineering: hope vs hype. Biochem Biophys Res Commun 292: 1-7.
43. Rosser AE, Dunnett SB (2003) Neural transplantation in patients with Huntington's disease. CNS Drugs 17: 853-867.
44. Shoji T, Ii M, Mifune Y, Matsumoto T, Kawamoto A, Kwon SM, Kuroda T, Kuroda R, Kurosaka M, Asahara T (2010) Local transplantation of human multipotent adipose-derived stem cells accelerates fracture healing viaenhanced osteogenesis and angiogenesis. Lab Invest 90: 637-649.
45. Tsutsumi S, Shimazu A, Miyazaki K, Pan H, Koike C, Yoshida E, Takagishi K, Kato Y (2001) Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun 288: 413-419.
46. Weir MD, Xu HH (2010) Culture human mesenchymal stem cells with calcium phosphate cement scaffolds for bone repair. J Biomed Mater Res B Appl Biomater, in press.
47. Wu Y, Wang J, Scott PG, Tredget EE (2007) Bone marrow-derived stem cells in wound healing: a review. Wound Repair Regen 15 Suppl 1: S18-S26.
48. Yoshioka T, Mishima H, Ohyabu Y, Sakai S, Akaogi H, Ishii T, Kojima H, Tanaka J, Ochiai N, Uemura T (2007) Repair of large osteochondral defects with allogeneic cartilaginous aggregates formed from bone marrowderived cells using RWV bioreactor. J Orthop Res 25: 1291-1298.